Related Experiment Videos
Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist
Abstract:
Secretion of amyloid precursor protein (APP) by cultured cells is coupled to several receptors, including m1 muscarinic (m1AChR), and is associated with decreased production of beta A4 amyloid. Secreted and cell-associated APP levels were measured in m1AChR-transfected PC12 cells stimulated with the non-selective agonist carbachol or the M1-selective agonist, AF102B. Secreted APP levels following stimulation with AF102B (5-60 min) were about half compared with carbachol. Yet, following 24 h stimulation with carbachol or AF102B, cell-associated APP levels were similarly decreased. This may be associated with a smaller reduction in APP secretion following 24 h stimulation with AF102B as compared with carbachol. AF102B may therefore have an advantage over non-selective muscarinic ligands for sustained decrease of cell-associated APP.
Insights
M1-selective agonists like AF102B reduce amyloid precursor protein (APP) secretion more effectively than non-selective agonists in cultured cells. This suggests a potential therapeutic advantage for sustained reduction of cell-associated APP.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Amyloid precursor protein (APP) secretion is linked to specific receptors, including the m1 muscarinic acetylcholine receptor (m1AChR).
- APP metabolism is implicated in neurological disorders, with reduced beta A4 amyloid production being a key outcome.
- Understanding APP regulation via m1AChR is crucial for developing targeted therapeutic strategies.
Purpose of the Study:
- To investigate the differential effects of M1-selective and non-selective muscarinic agonists on APP secretion and cell-associated levels.
- To evaluate the potential of AF102B, an M1-selective agonist, for sustained reduction of cell-associated APP.
Main Methods:
- Utilized m1AChR-transfected PC12 cells for experimental studies.
- Measured secreted and cell-associated APP levels following stimulation with carbachol (non-selective) and AF102B (M1-selective) at different time points (5-60 min and 24 h).
Main Results:
- AF102B stimulation resulted in approximately half the secreted APP levels compared to carbachol within 5-60 minutes.
- Both carbachol and AF102B similarly decreased cell-associated APP levels after 24 hours of stimulation.
- A smaller reduction in APP secretion was observed with 24-hour AF102B stimulation compared to carbachol, potentially explaining the sustained decrease in cell-associated APP.
Conclusions:
- M1-selective agonists, such as AF102B, demonstrate a distinct short-term effect on APP secretion compared to non-selective muscarinic ligands.
- AF102B may offer an advantage over non-selective muscarinic ligands for achieving a sustained reduction in cell-associated APP levels.
- These findings support the potential therapeutic utility of M1-selective agonists in managing conditions related to APP metabolism.